Welcome to Scop3P

Search for the desired protein with Uniprot accession, protein name/keyword, ProteomeXchange ID or PDB id

ZCCHV_HUMAN : Zinc finger CCCH-type antiviral protein 1

  • Zoom in and zoom out (both with mouse and buttons on the right top corner) to see modificationson the protein
  • Slide the chart to see other modifications (both with mouse and buttons on the right topcorner)
  • Hover on the modification to see more information and position on the structure.
PDB 
 AlphaFold
Phospho-sites

Showing 38 results

Swiss-Prot Position Modification Source Evidence Singly phosphorylated
101 SER PRIDE yes
114 SER PRIDE yes
249 SER PRIDE
257 SER UP, PRIDE Combined
267 SER UP, PRIDE Similarity yes
271 SER UP, PRIDE Combined
273 THR UP, PRIDE Combined
275 SER UP, PRIDE Combined
284 SER UP, PRIDE Combined
298 THR PRIDE yes
299 TYR PRIDE yes
302 SER UP, PRIDE Combined yes
310 SER PRIDE yes
321 THR PRIDE yes
322 SER PRIDE yes
326 THR PRIDE yes
327 SER UP, PRIDE Similarity yes
335 SER UP, PRIDE Combined yes
348 TYR PRIDE yes
355 SER UP, PRIDE Combined yes
361 SER PRIDE yes
375 THR PRIDE
378 SER UP, PRIDE Combined
380 THR PRIDE yes
387 SER UP, PRIDE Combined
390 SER PRIDE
393 THR UP, PRIDE Combined
403 THR PRIDE yes
407 SER UP, PRIDE Combined yes
408 SER PRIDE yes
410 TYR PRIDE yes
419 THR PRIDE yes
459 SER PRIDE yes
469 SER UP, PRIDE Combined
475 THR PRIDE
492 SER UP, PRIDE Combined yes
494 SER UP, PRIDE Combined yes
631 SER PRIDE yes

3D structure is not available

Display Settings

Hover over to see the values, zoom (in/out) or drag by using the mouse pointer.

Phosphorylated amino acids are colored red on the inner ring.

The first amino acid of the protein sequence is colored darker on each ring.

Phospho peptides

Showing 58 results

Sequence Modified position (Swiss-Prot) Peptide start Peptide end Modified position (Peptide) Number of projects
CNYSQSERNLCK 101 96 107 6 1
YSHEVLSEENFK 114 108 119 7 1
SRDRFFQGSQEFLASASASAER 249 249 270 1 1
SRDRFFQGSQEFLASASASAER 257 249 270 9 1
DRFFQGSQEFLASASASAER 257 251 270 7 2
FFQGSQEFLASASASAER 257 253 270 5 7
FFQGSQEFLASASASAER 267 253 270 15 1
SCTPSPDQISHR 271 271 282 1 5
SCTPSPDQISHR 273 271 282 3 15
SCTPSPDQISHRASLEDAPVDDLTRK 273 271 296 3 1
SCTPSPDQISHRASLEDAPVDDLTR 273 271 295 3 1
SCTPSPDQISHR 275 271 282 5 10
SCTPSPDQISHRASLEDAPVDDLTR 284 271 295 14 5
SCTPSPDQISHRASLEDAPVDDLTRK 284 271 296 14 1
ASLEDAPVDDLTR 284 283 295 2 14
ASLEDAPVDDLTRK 284 283 296 2 4
KFTYLGSQDR 298 296 305 3 1
KFTYLGSQDR 299 296 305 4 2
FTYLGSQDR 299 297 305 3 1
KFTYLGSQDR 302 296 305 7 2
FTYLGSQDR 302 297 305 6 6
ARPPSGSSK 310 306 314 5 1
ATDLGGTSQAGTSQR 321 315 329 7 1
ATDLGGTSQAGTSQR 322 315 329 8 1
ATDLGGTSQAGTSQR 326 315 329 12 2
ATDLGGTSQAGTSQR 327 315 329 13 2
FLENGSQEDLLHGNPGSTYLASNSTSAPNWK 335 330 360 6 7
FLENGSQEDLLHGNPGSTYLASNSTSAPNWK 348 330 360 19 1
FLENGSQEDLLHGNPGSTYLASNSTSAPNWK 355 330 360 26 1
SLTSWTNDQGAR 361 361 372 1 2
RKTVFSPTLPAAR 375 373 385 3 3
TVFSPTLPAAR 375 375 385 1 5
RKTVFSPTLPAAR 378 373 385 6 3
KTVFSPTLPAAR 378 374 385 5 2
TVFSPTLPAARSSLGSLQTPEAVTTRK 378 375 401 4 1
TVFSPTLPAAR 378 375 385 4 17
TVFSPTLPAAR 380 375 385 6 1
SSLGSLQTPEAVTTR 387 386 400 2 13
SSLGSLQTPEAVTTRK 387 386 401 2 3
SSLGSLQTPEAVTTR 390 386 400 5 3
SSLGSLQTPEAVTTRK 390 386 401 5 1
SSLGSLQTPEAVTTR 393 386 400 8 7
SSLGSLQTPEAVTTRK 393 386 401 8 4
KGTGLLSSDYR 403 401 411 3 1
GTGLLSSDYR 407 402 411 6 2
GTGLLSSDYR 408 402 411 7 1
KGTGLLSSDYR 410 401 411 10 3
KGTGLLSSDYRIINGK 410 401 416 10 1
GTGLLSSDYR 410 402 411 9 3
GTGLLSSDYRIINGK 410 402 416 9 1
SGTQDIQPGPLFNNNADGVATDITSTR 419 417 443 3 2
EISSPRIQDAGPASR 459 456 470 4 2
EISSPR 459 456 461 4 2
IQDAGPASRDVQATGRIADDADPR 469 462 485 8 1
IQDAGPASRDVQATGRIADDADPR 475 462 485 14 1
VALVNDSLSDVTSTTSSR 492 486 503 7 6
VALVNDSLSDVTSTTSSR 494 486 503 9 5
KNSNVDSSYLESLYQSCPR 631 629 647 3 1

Structures

Showing 0 results

PDB id Chain Method Resolution Stoichiometry Interfacing Molecule/Chain Complex Formation Significance Score (CSS) P-sites View Structure

Mutations

Showing 4 results

Swiss-Prot Position Amino acid (Wild type) Amino acid (Variant) Variant Type Disease
485 R K Polymorphism
565 H Q Polymorphism
701 Q E Polymorphism
851 T I Polymorphism